BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22250020)

  • 1. Newborn dried blood spot screening: residual specimen storage issues.
    Therrell BL; Hannon WH
    Pediatrics; 2012 Feb; 129(2):365-6. PubMed ID: 22250020
    [No Abstract]   [Full Text] [Related]  

  • 2. Public attitudes regarding the use of residual newborn screening specimens for research.
    Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
    Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citizens' values regarding research with stored samples from newborn screening in Canada.
    Bombard Y; Miller FA; Hayeems RZ; Carroll JC; Avard D; Wilson BJ; Little J; Bytautas JP; Allanson J; Axler R; Giguere Y; Chakraborty P
    Pediatrics; 2012 Feb; 129(2):239-47. PubMed ID: 22250019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the residual newborn screening dried blood sample litigation.
    Lewis MH
    J Law Med Ethics; 2015; 43 Suppl 1():32-5. PubMed ID: 25846160
    [No Abstract]   [Full Text] [Related]  

  • 5. State laws regarding the retention and use of residual newborn screening blood samples.
    Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
    Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental Consent for the Use of Residual Newborn Screening Bloodspots: Respecting Individual Liberty vs Ensuring Public Health.
    Bayefsky MJ; Saylor KW; Berkman BE
    JAMA; 2015 Jul; 314(1):21-2. PubMed ID: 26053685
    [No Abstract]   [Full Text] [Related]  

  • 7. MN Supreme Court rules on newborn screening samples.
    Minn Med; 2011 Dec; 94(12):18-9. PubMed ID: 22372040
    [No Abstract]   [Full Text] [Related]  

  • 8. Residual newborn screening samples for research: parental information needs for decision-making.
    Rothwell E; Clark L; Anderson R; Botkin JR
    J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed choice for newborn blood spot screening in the United Kingdom: a survey of parental perceptions.
    Nicholls SG; Southern KW
    Pediatrics; 2012 Dec; 130(6):e1527-33. PubMed ID: 23147970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research results: preserving newborn blood samples.
    Lewis MH; Scheurer ME; Green RC; McGuire AL
    Sci Transl Med; 2012 Nov; 4(159):159cm12. PubMed ID: 23136040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public support for the use of newborn screening dried blood spots in health research.
    Duquette D; Rafferty AP; Fussman C; Gehring J; Meyer S; Bach J
    Public Health Genomics; 2011; 14(3):143-52. PubMed ID: 21178324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mothers' Views on Longer Storage of Neonatal Dried Blood Spots for Specific Secondary Uses.
    van Teeffelen SR; Douglas CM; van El CG; Weinreich SS; Henneman L; Radstake M; Cornel MC
    Public Health Genomics; 2016; 19(1):25-33. PubMed ID: 26581038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two faces of patient advocacy: the current controversy in newborn screening.
    Arnold CG
    J Med Ethics; 2014 Aug; 40(8):558-62. PubMed ID: 23592379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois.
    Hart A; Petros M; Charrow J; Nash C; Wicklund C
    J Genet Couns; 2015 Jun; 24(3):482-90. PubMed ID: 25410141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention and research use of residual newborn screening bloodspots.
    Botkin JR; Goldenberg AJ; Rothwell E; Anderson RA; Lewis MH
    Pediatrics; 2013 Jan; 131(1):120-7. PubMed ID: 23209103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proxy consent and a national DNA databank: an unethical and discriminatory combination.
    Baumann TK
    Iowa Law Rev; 2001 Jan; 86(2):667-701. PubMed ID: 16184651
    [No Abstract]   [Full Text] [Related]  

  • 17. Common criteria among States for storage and use of dried blood spot specimens after newborn screening.
    Petrini C; Olivieri A; Corbetta C; Cerone R; D'Agnolo G; Bompiani A
    Ann Ist Super Sanita; 2012; 48(2):119-21. PubMed ID: 22751553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
    Dhondt JL
    J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of parents of children with serious health conditions regarding residual bloodspot use.
    Nagaraj CB; Rothwell E; Hart K; Latimer S; Schiffman JD; Botkin JR
    Public Health Genomics; 2014; 17(3):141-8. PubMed ID: 24713606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research.
    Rothwell E; Anderson R; Botkin J
    Policy Polit Nurs Pract; 2010 Feb; 11(1):5-12. PubMed ID: 20457727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.